Beta-Lactamase and Ambler classification

β-lactamase enzymes are capable of hydrolysing the β-lactam rings (the active site) of β-lactam antibiotics; thereby deactivating their antibacterial properties.

  • It is observed in both gram-positive and gram-negative bacteria.
  • They are plasmid coded, and transferred from one bacterium to other mostly by conjugation, (except in Staphylococcus aureus where they are transferred by transduction).
  • Beta lactamases can be classified in two ways:
    • Ambler’s classification (structural or molecular classification).
    • Bush Jacoby Medeiros classification or functional (phenotypic)—Advanced and complex classification.

Beta-Lactamase and Ambler classification

Ambler classification of beta-lactamases

Class A-ESBL (Extended spectrum β-lactamases)

Organisms producing ESBL enzymes are resistant to all Penicillins and 1st, 2nd and 3rd generation cephalosporins and monobactams, however remain sensitive to carbapenems and cephamycins.

  • Resistance can be overcome by β-lactam + β-lactamase inhibitor (e.g. sulbactum or clavulanic acid).
  • Detected by Combination disk test (Ceftazidime and cetftazidime + clavulanic acid), Three dimensional test (best method).

Class B-MBL (Metallo beta-lactamase)

These organisms are resistant to all those antibiotics to which AmpC beta-lactamase producers are resistant plus they are resistant to carbapenems.

  • Resistance cannot be overcome by β-lactam + β-lactamase inhibitor combination.
  • Detected by EDTA disk synergy test, modified Hodge test.

Class C- AmpC beta-lactamase

These organisms are resistant to all those antibiotics to which ESBL producers are resistant plus they are resistant to cephamycins (e.g. cefoxitin and cefotetan ). But they are sensitive to carbapenems.

  • Resistance cannot be overcome by β-lactam + β-lactamase inhibitor combination.
  • Detected by AmpC disk test using cefoxitin disk.

Class D- oxacillinase

  • Resistance can be overcome by β-lactam + β-lactamase inhibitor combination.

About Author

Photo of author

Sagar Aryal, PhD

Dr. Sagar Aryal is a microbiologist, researcher, and science communicator from Nepal. He is also co-founder and Research Head of the Department of Natural Products at the Kathmandu Research Institute for Biological Sciences (KRIBS), where he leads research on natural product discovery and microbial biodiversity. Dr. Aryal earned his Ph.D. in Microbiology from Tribhuvan University, Kathmandu, Nepal, in 2025, supported by a DAAD Research Grant and a University Grants Commission (UGC) Nepal Ph.D. Fellowship. His research interests include Actinomycetes, Myxobacteria, microbial taxonomy, and natural products, particularly the discovery of bioactive compounds with potential pharmaceutical applications. He isolated and identified Nocardia nepalensis, a novel bacterial species from Nepal, contributing to understanding microbial diversity in the region. Dr. Aryal has published more than 16 research articles in international journals and contributed three book chapters to established academic publications. He has presented scientific research findings and developed international research collaborations through visits to more than 18 countries across Asia, Europe, North America, and Oceania. From 2023 to 2025, he served as the American Society for Microbiology (ASM) Young Ambassador to Nepal. Since December 2025, he has served as an Editorial Board Member of Scientific Reports, a Nature Portfolio journal. In recognition of his scientific contributions, Dr. Aryal received the NAST Science and Technology Youth Award 2025 from the Nepal Academy of Science and Technology. He previously received the Frs. Locke and Stiller Research Award (LSRA) for the 2017-2018 cycle from St. Xavier's College, Kathmandu, and a Nepal Academy of Science and Technology (NAST) Research Grant for 2017-2018. Alongside his scientific career, Dr. Aryal has more than 15 years of experience in blogging, content writing, and search engine optimization (SEO).